Authors:
S. Thomas Analytical Research Department, Jubilant Life Sciences Ltd., R&D Centre, C-26, Sector-59, Noida, Uttar Pradesh, 201 301, India

Search for other papers by S. Thomas in
Current site
Google Scholar
PubMed
Close
,
S. K. Paul Analytical Research Department, Jubilant Life Sciences Ltd., R&D Centre, C-26, Sector-59, Noida, Uttar Pradesh, 201 301, India

Search for other papers by S. K. Paul in
Current site
Google Scholar
PubMed
Close
,
A. Agarwal Analytical Research Department, Jubilant Life Sciences Ltd., R&D Centre, C-26, Sector-59, Noida, Uttar Pradesh, 201 301, India

Search for other papers by A. Agarwal in
Current site
Google Scholar
PubMed
Close
, and
C. S. Mathela Department of Chemistry, Kumaun University, DSB Campus, Nainital, Uttarakhand, 263 001, India

Search for other papers by C. S. Mathela in
Current site
Google Scholar
PubMed
Close
Open access

Summary

Galantamine hydrobromide was subjected to oxidative stress degradation using hydrogen peroxide and analyzed as per the chromatographic conditions described in European Pharmacopoeia. The drug showed considerable degradation at ambient temperature resulting in the formation of two degradation products at relative retention times (RRTs) 0.63 and 2.52. The minor degradant at RRT 0.63 was identified as galantamine N-oxide. The principal degradant formed at RRT 2.52 was found to be unknown and has not been reported previously. The unknown impurity was identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) followed by isolation using semi-preparative high-performance liquid chromatography (HPLC). The isolated impurity was characterized using one-dimensional, two-dimensional nuclear magnetic resonance spectroscopy (1D and 2D NMR) and elemental analysis (EA). The principal degradant was found to be formed due to the generation of bromine and subsequent attack on the aromatic ring via in situ reaction between hydrogen bromide and hydrogen peroxide. The unknown impurity was characterized as (4aS,6R,8aS)-5,6,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-methyl-4aH-[1]benzofuro [3a,3,2-ef] [2] benzazepin-6-ol.

  • [1]. S. Lilienfeld 2002 Galantamine-a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease, CNS Drug Rev. 8 159.

    • Search Google Scholar
    • Export Citation
  • [2]. A. Maelicke A. Schrattenholz M. Samochocki M. Radina E.X. Albuquerque 2000 Behav. Brain Res. 113 199.

  • [3]. Y.H. Hsieh Y.H. Yang H.H. Yeh P.C. Lin S.H. Chen 2009 Electrophoresis 30 644.

  • [4]. R. Mol E. Kragt I. Jimidar G.J. de Jong G.W. Somsena 2006 J. Chromatogr., B 843 283.

  • [5]. A. Rizzi R. Schuh A. Bruckner B. Cvitkovich L. Kremser U. Jordis J. Frohlich B. Kuenburg L. Czollner 1999 J. Chromatogr., B 730 167.

    • Search Google Scholar
    • Export Citation
  • [6]. H.A. Claessens M.V. Thiel P. Westra A.M. Soeterboek 1983 J. Chromatogr. B 275 345.

  • [7]. J. Tencheva I. Yamboliev J. Zhivkova 1987 J. Chromatogr., B 421 396.

  • [8]. G. S. J. Mannens C.A.W. Snel J. Hendrickx T. Verhaeghe L.L. Jeune W. Bode L.V. Beijsterveldt K. Lavrijsen J. Leempoels N.V. Osselaer A.V. Peer W. Meuldermans 2002 Drug Metab. Disp. 30 553.

    • Search Google Scholar
    • Export Citation
  • [9]. J. Monbaliu T. Verhaeghe B. Williems W. Bode K. Lavrijsen 2003 Arzneim. Forsch. Drug Res. 53 486.

  • [10]. T. Verhaeghe L. Diels R. de Vries M. De Meulder J. de Jong 2003 J. Chromatogr., B 789 337.

  • [11]. W.C. Paul J. Scatina F. Samuel 1995 Sisenwine 18 1801.

  • [12]. R.V.S. Nirogi V. N. Kandikere K. Mudigonda S. Maurya 2007 J. Chromatogr. Sci. 45 97.

  • [13]. V. Ravinder S. Ashok A.V.S.S. Prasad G. Balaswamy Y.R. Kumar B. Vijaya Bhaskar 2008 Chromatography 67 331.

  • [14]. United States Pharmacopeia, 34, vol.2, 2011, 29452948.

  • [15]. European Pharmacopoeia, 7th edn., 2010, vol. 2, 20832086.

  • [16]. L.A. Marques I. Maada F.J.J. Kanterb H. Lingemana H. Irth W.M.A. Niessen M. Gieraa 2011 J. Pharm. Biomed. Anal. 55 85.

  • [17]. C.M. Halpin C. Reilly J.J. Walsh 2010 J. Chem. Ed. 87 1242.

  • [18]. V. Dora J. Ilias V. A. Willy V. Tom R. Dirk D.S. Maurits 2005 Electrophoresis 26 1541.

  • [19]. ICH Guideline, Q1A (R2) Stability Testing of New Drug Substances and Products, step 4, February 6, 2003.

  • [20]. J. Malakova M. Nobilis Z. Svoboda M. Lisa M. Holcapek J. Kvetina J. Klimes J. Vladimir 2007 Chromatogr., B 853 265.

  • Collapse
  • Expand

Senior editors

Editor(s)-in-Chief: Kowalska, Teresa (1946-2023)

Editor(s)-in-Chief: Sajewicz, Mieczyslaw, University of Silesia, Katowice, Poland

Editors(s)

  • Danica Agbaba, University of Belgrade, Belgrade, Serbia
  • Łukasz Komsta, Medical University of Lublin, Lublin, Poland
  • Ivana Stanimirova-Daszykowska, University of Silesia, Katowice, Poland
  • Monika Waksmundzka-Hajnos, Medical University of Lublin, Lublin, Poland

Editorial Board

  • Ravi Bhushan, The Indian Institute of Technology, Roorkee, India
  • Jacek Bojarski, Jagiellonian University, Kraków, Poland
  • Bezhan Chankvetadze, State University of Tbilisi, Tbilisi, Georgia
  • Michał Daszykowski, University of Silesia, Katowice, Poland
  • Tadeusz H. Dzido, Medical University of Lublin, Lublin, Poland
  • Attila Felinger, University of Pécs, Pécs, Hungary
  • Kazimierz Glowniak, Medical University of Lublin, Lublin, Poland
  • Bronisław Glód, Siedlce University of Natural Sciences and Humanities, Siedlce, Poland
  • Anna Gumieniczek, Medical University of Lublin, Lublin, Poland
  • Urszula Hubicka, Jagiellonian University, Kraków, Poland
  • Krzysztof Kaczmarski, Rzeszow University of Technology, Rzeszów, Poland
  • Huba Kalász, Semmelweis University, Budapest, Hungary
  • Katarina Karljiković Rajić, University of Belgrade, Belgrade, Serbia
  • Imre Klebovich, Semmelweis University, Budapest, Hungary
  • Angelika Koch, Private Pharmacy, Hamburg, Germany
  • Piotr Kus, Univerity of Silesia, Katowice, Poland
  • Debby Mangelings, Free University of Brussels, Brussels, Belgium
  • Emil Mincsovics, Corvinus University of Budapest, Budapest, Hungary
  • Ágnes M. Móricz, Centre for Agricultural Research, Budapest, Hungary
  • Gertrud Morlock, Giessen University, Giessen, Germany
  • Anna Petruczynik, Medical University of Lublin, Lublin, Poland
  • Robert Skibiński, Medical University of Lublin, Lublin, Poland
  • Bernd Spangenberg, Offenburg University of Applied Sciences, Germany
  • Tomasz Tuzimski, Medical University of Lublin, Lublin, Poland
  • Yvan Vander Heyden, Free University of Brussels, Brussels, Belgium
  • Adam Voelkel, Poznań University of Technology, Poznań, Poland
  • Beata Walczak, University of Silesia, Katowice, Poland
  • Wiesław Wasiak, Adam Mickiewicz University, Poznań, Poland
  • Igor G. Zenkevich, St. Petersburg State University, St. Petersburg, Russian Federation

 

KOWALSKA, TERESA (1946-2023)
E-mail: kowalska@us.edu.pl

SAJEWICZ, MIECZYSLAW
E-mail:msajewic@us.edu.pl

Indexing and Abstracting Services:

  • Science Citation Index
  • Sci Search
  • Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences
  • SCOPUS
  • GoogleScholar
  • Index Copernicus
  • CABI
  • CABELLS Journalytics

2023  
Web of Science  
Journal Impact Factor 1.7
Rank by Impact Factor Q3 (Chemistry, Analytical)
Journal Citation Indicator 0.43
Scopus  
CiteScore 4.0
CiteScore rank Q2 (General Chemistry)
SNIP 0.706
Scimago  
SJR index 0.344
SJR Q rank Q3

Acta Chromatographica
Publication Model Online only
Gold Open Access
Submission Fee none
Article Processing Charge 400 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Acta Chromatographica
Language English
Size A4
Year of
Foundation
1988
Volumes
per Year
1
Issues
per Year
4
Founder Institute of Chemistry, University of Silesia
Founder's
Address
PL-40-007 Katowice, Poland, Bankowa 12
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2083-5736 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2024 0 15 6
May 2024 0 2 1
Jun 2024 0 27 7
Jul 2024 0 10 6
Aug 2024 0 38 8
Sep 2024 0 39 3
Oct 2024 0 9 1